The only thing I have heard that I would consider a negative is that the CEO is retiring and they are searching for a new CEO. There is the info about the trial combined with the Bavarian Nordic drug but that seemed like a problem for the other. At this point, I wish I had never seen it and mentioned it here. It makes no sense to me. If not for the known revs and profits that are coming I would just dump it and move on.